Hypercoagulation after Hospital Discharge in Acute Severe Ulcerative Colitis: A Prospective Study.
Griffiths BJ. et al, (2024), Clin Gastroenterol Hepatol
Tranexamic acid versus placebo to prevent bleeding in patients with haematological malignancies and severe thrombocytopenia (TREATT): a randomised, double-blind, parallel, phase 3 superiority trial.
TREATT Trial Investigators None., (2024), Lancet Haematol
Myocardial iron intake following intravenous iron therapy with ferric carboxymaltose is sustained at 1 year despite recurrence of iron deficiency.
Piechnik SK. et al, (2024), Br J Haematol
Transfusion Camp: The UK experience and its value in improving knowledge of transfusion medicine among postgraduate trainees.
Aggarwal A. et al, (2024), Transfus Med
Intravenous iron therapy results in rapid and sustained rise in myocardial iron content through a novel pathway.
Vera-Aviles M. et al, (2024), Eur Heart J
Haemostatic therapies for stroke due to acute, spontaneous intracerebral haemorrhage.
Eilertsen H. et al, (2023), Cochrane Database Syst Rev, 10
Desmopressin for patients with spontaneous intracerebral haemorrhage taking antiplatelet drugs (DASH): a UK-based, phase 2, randomised, placebo-controlled, multicentre feasibility trial.
Desborough MJR. et al, (2023), Lancet Neurol, 22, 557 - 567
Platelet factor XIII-A regulates platelet function and promotes clot retraction and stability
Mitchell JL. et al, (2023), Research and Practice in Thrombosis and Haemostasis, 7
Daratumumab for refractory immune-mediated thrombotic thrombocytopenic purpura.
Aggarwal A. et al, (2023), British journal of haematology
Antiplatelet Resistance: A Review of Concepts, Mechanisms, and Implications for Management in Acute Ischemic Stroke and Transient Ischemic Attack
Krishnan K. et al, (2023), Stroke: Vascular and Interventional Neurology
Real world reduction in red cell transfusion with restrictive transfusion threshold in haematology inpatients
Pervaiz O. et al, (2023), Transfusion Medicine
Pirtobrutinib results in reversible platelet dysfunction compared to ibrutinib and acalabrutinib.
Bye AP. et al, (2022), Haematologica
Drug-induced thrombotic thrombocytopenic purpura: A systematic review and review of European and North American pharmacovigilance data.
Schofield J. et al, (2022), Br J Haematol
Intraoperative cell salvage using swab wash and serial thromboelastography in elective abdominal aortic aneurysm surgery involving massive blood loss.
Stoneham MD. et al, (2022), Br J Haematol
Outcomes and management of pregnancy in women with bleeding disorder of unknown cause.
Castle D. et al, (2022), J Thromb Haemost
Platelet transfusion and anticoagulation in haematological cancer-associated thrombosis and thrombocytopenia: the CAVEaT multi-centre prospective cohort.
Booth S. et al, (2022), J Thromb Haemost
Acquired thrombotic thrombocytopenic purpura: A rare disease associated with BNT162b2 vaccine: Comment from Doyle et al.
Doyle AJ. et al, (2022), J Thromb Haemost, 20, 781 - 783
Risk of thrombosis with thrombocytopenia syndrome after COVID-19 vaccination prior to the recognition of vaccine-induced thrombocytopenia and thrombosis: A self-controlled case series study in England.
Higgins H. et al, (2022), Res Pract Thromb Haemost, 6
Is there a role for Desmopressin as an alternative to platelet transfusion prior to procedures or Radiological InterVEntions in thrombocytopenic critically ill patients (DRIVE)? Results of a randomised double-blind placebo-controlled feasibility trial
Desborough M. et al, (2022), BRITISH JOURNAL OF HAEMATOLOGY, 197, 40 - 41